Advance Search
Volume 37 Issue 11
Nov.  2021
Turn off MathJax
Article Contents
WANG Yi, CHEN Jia-heng, HU Xiu-jing, . Implications of health technology assessment practice in eight countries for Healthy China Initiative[J]. Chinese Journal of Public Health, 2021, 37(11): 1713-1717. doi: 10.11847/zgggws1127261
Citation: WANG Yi, CHEN Jia-heng, HU Xiu-jing, . Implications of health technology assessment practice in eight countries for Healthy China Initiative[J]. Chinese Journal of Public Health, 2021, 37(11): 1713-1717. doi: 10.11847/zgggws1127261

Implications of health technology assessment practice in eight countries for Healthy China Initiative

doi: 10.11847/zgggws1127261
  • Received Date: 2019-12-02
    Available Online: 2021-11-17
  • Publish Date: 2021-11-10
  • Health technology assessment (HTA) is an applied discipline that provides research evidences to improve health and decision-making. With the emergence of new technologies and the growing health-care demand in disease prevention and control, the need for HTA becomes crucial in the implementation of Healthy China Initiative. The study presented a brief introduction on application of HTA and its main characteristics in eight countries including Australia, Canada, Germany, France, Spain, United Kingdom, Thailand, and South Korea. The implications of HTA practices in the eight countries for Healthy China Initiative and the significance of HTA application in China were also discussed.
  • loading
  • [1]
    陈洁, 于德志. 卫生技术评估[M]. 北京: 人民卫生出版社, 2013.
    [2]
    傅卫, 赵琨. 中国卫生技术评估的发展与挑战[J]. 卫生经济研究, 2019, 36(3): 3 – 5.
    [3]
    Maynard A. The powers and pitfalls of payment for perfor-mance[J]. Health Economics, 2012, 21(1): 3 – 12. doi: 10.1002/hec.1810
    [4]
    陈英耀, 魏艳, 王薇, 等. 中国卫生技术评估的实践与挑战[J]. 中国农村卫生事业管理, 2019, 39(2): 83 – 87. doi: 10.3969/j.issn.1005-5916.2019.02.003
    [5]
    李颖. 全民普惠制的澳大利亚药品目录制度[J]. 医院院长论坛, 2009, 6(5): 60 – 63. doi: 10.3969/j.issn.1673-1700.2009.05.019
    [6]
    郭祖德, 周萍, 夏志远, 等. 加拿大卫生技术评估机构研究: 以加拿大药物和卫生技术局为例[J]. 中国卫生资源, 2016, 19(3): 187 – 190.
    [7]
    Sumeet S. INAHTA Workshop: how to set up an HTA agency[EB/OL].[2013 – 11 – 22]. http://www.who.int/medical_devices/global_forum/Workshop_08_HTA_INAHTA_4.pdf.
    [8]
    Menon D, Topfer LA. Health technology assessment in Canada: a decade in review[J]. International Journal of Technology Assessment in Health Care, 2000, 16(3): 896 – 902. doi: 10.1017/S0266462300102168
    [9]
    李珍, 赵青. 德国社会医疗保险治理体制机制的经验与启示[J]. 德国研究, 2015, 30(2): 86 – 99.
    [10]
    聂春雷, 姚建红, 冯光, 等. 法国的卫生服务和医疗保险体系[J]. 中国卫生经济, 2005, 24(5): 67 – 68. doi: 10.3969/j.issn.1003-0743.2005.05.024
    [11]
    The Haute Autorité de santé (HAS). French national authority for health[EB/OL].[2013 – 01 – 25]. https://www.has-sante.fr/jcms/r_1455134/en/about-has.
    [12]
    Huguier M, Rossignol C. French national authority for health[J]. Bulletin de l'Académie Nationale de Médecine, 2013, 197(7): 1409 – 1418. doi: 10.1016/S0001-4079(19)31466-9
    [13]
    Sampietro-Colom L, Asua J, Briones E, et al. History of health technology assessment: Spain[J]. International Journal of Techno-logy Assessment in Health Care, 2009, 25(S1): 163 – 173.
    [14]
    Lehoux P, Battista RN, Granados A, et al. International Master′s Program in health technology assessment and management: assessment of the first edition (2001 – 2003)[J]. International Journal of Technology Assessment in Health Care, 2005, 21(1): 104 – 112. doi: 10.1017/S0266462305050130
    [15]
    Briggs A, Sculpher M, Claxton K. Decision modelling for health economic evaluation[R]. Oxford: Oxford University Press, 2006.
    [16]
    Department of Health. Report of the triennial review of the national institute for health and care excellence[R]. London: Department of Health, 2015.
    [17]
    National Institute for Health and Care Excellence (NICE). Guide to the processes of technology appraisal (Process and Methods Guides No.19)[R]. London: NICE, 2014.
    [18]
    吕兰婷, 朱晓稳. 泰国卫生技术评估决策转化机制探析[J]. 中国卫生信息管理杂志, 2018, 15(2): 170 – 174.
    [19]
    Kim L, Kim JA, Kim S. A guide for the utilization of health insurance review and assessment service national patient samples[J]. Epidemiology and Health, 2014, 36: e2014008.
    [20]
    Ahn J, Kim G, Suh HS, et al. Social values and healthcare priority setting in Korea[J]. Journal of Health Organization and Manage-ment, 2012, 26(3): 343 – 350. doi: 10.1108/14777261211238981
    [21]
    Sivalal S. Health technology assessment in the Asia Pacific region[J]. International Journal of Technology Assessment in Health Care, 2009, 25(S1): 196 – 201. doi: 10.1017/S0266462309090631
    [22]
    Yang BM, Bae EY, Kim J. Economic evaluation and pharma-ceutical reimbursement reform in South Korea′s National Health Insurance[J]. Health Affairs (Millwood), 2008, 27(1): 179 – 187. doi: 10.1377/hlthaff.27.1.179
    [23]
    李芬, 王常颖, 王力男, 等. 老龄化与医疗费用增长的国际研究进展与启示[J]. 中国卫生经济, 2018, 37(3): 94 – 96.
    [24]
    任明, 孙晓, 郭利平. 中国2006-2016年适宜卫生技术推广应用制约因素系统评价[J]. 中国公共卫生, 2018, 34(6): 868 – 870. doi: 10.11847/zgggws1118063
    [25]
    李艳博, 陈校云, 余中光, 等. 欧洲卫生技术评估网络的核心评估模型及应用[J]. 中国卫生信息管理杂志, 2016, 13(4): 370 – 375.
    [26]
    吕兰婷, 付荣华. 我国医疗技术管理中引入医疗技术评估的路径探讨[J]. 中国医院管理, 2016, 36(12): 17 – 20.
    [27]
    董恒进. 卫生技术评估的进展[J]. 中华医院管理杂志, 2000, 16(3): 157 – 162. doi: 10.3760/j.issn:1000-6672.2000.03.009
    [28]
    茅艺伟, 陈英耀, 唐檬, 等. 国内部分卫生技术评估机构现状分析[J]. 中国卫生质量管理, 2015, 22(3): 77 – 80.
  • 加载中

Catalog

    通讯作者: 陈斌, bchen63@163.com
    • 1. 

      沈阳化工大学材料科学与工程学院 沈阳 110142

    1. 本站搜索
    2. 百度学术搜索
    3. 万方数据库搜索
    4. CNKI搜索
    Article views (227) PDF downloads(23) Cited by()
    Proportional views
    Related

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return